It has its most important asset in the satisfaction of its customers, being able to demonstrate that 100% of customers who have responded to the satisfaction survey in the last 8 years, would recommend Burdinola.
Burdinola, a company dedicated to laboratory projects in different sectors and manufacturer of safety equipment such as fume cupboards and technical laboratory furniture, consolidates its leadership by closing the year 2023 with an increase in turnover of 11%, which represents an increase of 60% in the last 4 years and 300% in the last 8 years.
The new strategic plan for the period 2024-2027 has recently been approved, the main axes of which are its constant innovative activity, strengthening the new Design and Build concept, doubling Burdinola Service, diversification and intrapreneurship, consolidation in key markets and the opening of new subsidiaries.
The company’s profitability and financial situation is a strong point that gives confidence to its demanding customers around the world. As a benchmark company in its sector, its innovative activity is maintained from its origins with more than 7000 product references, being one of the main axes of the new strategic plan. The fume cupboards are one of Burdinola’s hallmarks and the maximum expression of its technological capacity. The new top-level range of eFlex fume cupboards combines the concepts of efficiency, eco-design, flexibility and connectivity. Burdinola’s new fume cupboards have been tested in test laboratories in the most complex conditions and subjected to demanding tests with an excellent response, resulting in a safe and efficient operation.
We also highlight its latest innovations worldwide, the Nano Chamber and the Api Chamber, new equipment to work safely with nanoparticles and active pharmaceutical ingredients respectively. The latter, together with the ventilated weighing table, are new developments focused on the pharmaceutical sector where Burdinola seeks to position itself as a reference partner in equipment for the pharmaceutical industry. With these new developments, Burdinola consolidates even more in the pharmaceutical industry.
Another axis of the new strategic plan focuses on Design & Build projects. This new methodology created by Burdinola, which has success cases in clients such as Faes Farma or Moderna, is having a total satisfaction among its clients. Burdinola assumes the responsibility of the globality of the project in all its phases working as a unique partner for its clients, leading from the design to the integral execution of projects from a perspective of excellence and professionalism.
Burdinola Service, on the other hand, is the result of Burdinola’s commitment to safety as the main hallmark and differentiation of the brand. It is a division dedicated to reinforcing the safety and efficiency of laboratories through a range of specialized services covering audits, verifications, maintenance and/or after-sales service. In the new strategic plan, this business unit is strengthened and it is expected to double its current turnover by 2027, since it will also provide service to equipment not manufactured by Burdinola.
Con todo ello, busca incrementar su liderazgo en sus mercados estratégicos y proponer nuevas soluciones a sus clientes. Burdinola es actualmente líder absoluto en el mercado nacional y líder en proyectos privados en países como Francia, Bélgica, Colombia y Perú. La diversidad geográfica de sus proyectos hace que hoy cuente con 5 delegaciones en España, así como filiales en Francia, Benelux, Italia, Dubai, México, Perú y Colombia y distribuidores en numerosos países. El nuevo plan estratégico se centra también en nuevos mercados en los que se prevé la creación de nuevas filiales. Con todo ello, y hasta la fecha, Burdinola ha realizado más de 8000 proyectos en más de 50 países y tiene su activo más importante en la satisfacción de sus clientes, pudiendo demostrar que el 100% de los clientes que han respondido a la encuesta de satisfacción en los últimos 8 años, recomendarían Burdinola.
